Modern Hybrid Imaging in Patients With OSCC - Trial NCT04280159
Access comprehensive clinical trial information for NCT04280159 through Pure Global AI's free database. This phase not specified trial is sponsored by Wuerzburg University Hospital and is currently Completed. The study focuses on Neoplasm. Target enrollment is 265 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Wuerzburg University Hospital
Timeline & Enrollment
N/A
Jun 28, 2013
Dec 31, 2018
Primary Outcome
Diagnostic accuracy of FGD-PET/CT to detect the primary tumor,Diagnostic accuracy of FGD-PET/CT to detect lymph nodes metastases,Diagnostic accuracy of FGD-PET/CT to detect distant lymph node metastases.
Summary
Prospective diagnostic study to determine the diagnostic accuracy of preoperative
 18F--fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in
 detecting local tumor extent, cervical lymph node metastases and distant metastases/secondary
 primary tumor.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04280159
Non-Device Trial